🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 21 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/09/2018 153,13 154,97 151,33 154,56 +0,95% 2,38% 618.100
24/09/2018 150,29 153,50 148,07 153,10 +3,73% 3,61% 1.065.800
21/09/2018 151,90 152,50 146,72 147,59 -3,43% 3,81% 1.661.800
20/09/2018 152,59 154,53 152,15 152,83 +0,58% 1,56% 659.300
19/09/2018 153,86 154,97 150,50 151,95 -1,06% 2,91% 588.400
18/09/2018 153,02 155,67 150,01 153,58 +0,81% 3,70% 890.600
17/09/2018 152,03 152,90 149,36 152,35 -0,27% 2,33% 1.103.900
14/09/2018 151,26 154,91 150,21 152,76 +1,70% 3,11% 1.223.400
13/09/2018 151,00 156,17 146,16 150,21 -0,37% 6,63% 1.360.100
12/09/2018 144,52 151,22 144,35 150,77 +5,07% 4,75% 1.590.100
11/09/2018 139,55 143,55 137,01 143,49 +2,35% 4,69% 788.300
10/09/2018 142,89 143,03 138,70 140,20 -1,76% 3,03% 821.800
07/09/2018 139,54 143,29 138,01 142,71 +0,89% 3,78% 693.400
06/09/2018 142,27 145,35 140,50 141,45 +0,49% 3,41% 1.076.200
05/09/2018 143,29 144,00 137,51 140,76 -1,88% 4,53% 952.100
04/09/2018 137,46 144,30 136,50 143,45 +3,92% 5,67% 1.015.300
31/08/2018 138,83 139,50 136,50 138,04 -1,31% 2,16% 649.100
30/08/2018 140,01 143,25 137,26 139,87 +0,27% 4,28% 1.108.100
29/08/2018 135,21 141,76 133,82 139,49 +3,53% 5,87% 1.056.000
28/08/2018 135,05 135,49 131,00 134,73 +0,22% 3,32% 602.700
27/08/2018 134,43 137,55 132,84 134,44 +0,90% 3,50% 532.900
24/08/2018 134,24 136,47 131,27 133,24 -1,06% 3,87% 607.500
23/08/2018 136,00 137,96 132,35 134,67 +0,17% 4,13% 648.600
22/08/2018 129,42 135,56 128,51 134,44 +4,10% 5,45% 670.300
21/08/2018 127,34 131,01 126,45 129,14 +1,18% 3,58% 492.000
20/08/2018 130,74 132,78 127,46 127,63 -2,01% 4,07% 639.400
17/08/2018 130,01 131,00 127,43 130,25 +0,52% 2,75% 732.700
16/08/2018 127,99 133,30 127,99 129,58 +3,07% 4,15% 1.528.900
15/08/2018 123,61 126,06 119,58 125,72 +0,68% 5,24% 920.400
14/08/2018 129,30 129,33 122,03 124,87 -1,83% 5,65% 1.107.000